Social Anxiety Disorders (SAD) Ongoing Global Clinical Trials Analysis and Outlook

  • ID: 4585335
  • Report
  • Region: Global
  • 87 pages
  • VPA Research
10 % OFF
until Nov 30th 2018
1 of 3
Social Anxiety Disorders (SAD) ongoing clinical trials report provides comprehensive analysis and trends in global Social Anxiety Disorders (SAD) disease clinical trials. The research work analyzes the ongoing Social Anxiety Disorders (SAD) clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Social Anxiety Disorders (SAD) treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Social Anxiety Disorders (SAD) clinical trials.

Scope of the Report:
  • Ongoing Social Anxiety Disorders (SAD) clinical trials across regions
  • Trial information by Phase and Subjects recruited
  • Trial information by status, type, sponsor type
  • Drugs used for treatment of Social Anxiety Disorders (SAD)
  • Both observational and interventional trials analyzed
  • Leading companies and universities participating in Social Anxiety Disorders (SAD) clinical trials
Reasons to Buy:
  • Track competition and design competitive advantages
  • Identify right partners to associate with for further research
  • Evaluate potential opportunities available in further clinical trials of the disease
  • Formulate business development strategies through success rates of clinical trials
  • Identify quick markets for recruiting subjects based on trials count by each market
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Table of Contents
1.1 List of Figures
1.2 List of Tables

2 Key Findings, 2018
2.1 Snapshot
2.2 Overview of Social Anxiety Disorders (SAD) Trials

3 Clinical Trials Trends to 2022
3.1 Ongoing Social Anxiety Disorders (SAD) Trials by Phase
3.2 Ongoing Social Anxiety Disorders (SAD) Trials by Type
3.3 Ongoing Social Anxiety Disorders (SAD) Trials by Recruitment Status

4 Country Level Analysis
4.1 Region wise Ongoing Social Anxiety Disorders (SAD) Trials
4.2 Top 10 Countries conducting Social Anxiety Disorders (SAD) Trials
4.3 Trials in Emerging and Developing Economies

5 Company Level Analysis
5.1 Ongoing Social Anxiety Disorders (SAD) Trials by Sponsor Type
5.2 Social Anxiety Disorders (SAD) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 Enrolment Trends to 2022
6.1 Subjects Recruited for Social Anxiety Disorders (SAD) Trials by year
6.2 Subjects Recruited for Social Anxiety Disorders (SAD) Trials by Phase
6.3 Subjects Recruited for Social Anxiety Disorders (SAD) Trials by Trial Type
6.4 Subjects Recruited for Social Anxiety Disorders (SAD) Trials by Recruitment Status

7 Ongoing Trials- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company Details
7.1 Ongoing Social Anxiety Disorders (SAD) Trials- Phase 1
7.2 Ongoing Social Anxiety Disorders (SAD) Trials- Phase 2
7.3 Ongoing Social Anxiety Disorders (SAD) Trials- Phase 3
7.4 Ongoing Social Anxiety Disorders (SAD) Trials- Phase 4

8 Appendix
8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List of Figures
Figure 1: Social Anxiety Disorders (SAD)- Clinical Trials by Country
Figure 2: Social Anxiety Disorders (SAD)- Clinical Trials by Phase of Development, 2018
Figure 3: Social Anxiety Disorders (SAD)- Clinical Trials by Status, 2018
Figure 4: Social Anxiety Disorders (SAD)- Clinical Trials by Type, 2018
Figure 5: Social Anxiety Disorders (SAD)- Clinical Trials Split by Region, 2000-2018
Figure 6: Social Anxiety Disorders (SAD)- Clinical Trials by Type of Economy, 2018
Figure 7: Social Anxiety Disorders (SAD)- Enrolment by Phase, 2018
Figure 8: Social Anxiety Disorders (SAD)- Enrolment by Trial Type, 2018
Figure 9: Social Anxiety Disorders (SAD)- Enrolment by Recruitment Status, 2018
Figure 10: Social Anxiety Disorders (SAD)- Clinical Trials by Sponsor Type, 2018
Figure 11: Social Anxiety Disorders (SAD)- Enrolment by Type of Sponsors
Figure 12: Social Anxiety Disorders (SAD)- Enrolment by Leading Sponsors

List of Tables
Table 1: Social Anxiety Disorders (SAD)- Clinical Trials by Sponsor Type, 2018
Table 2: Social Anxiety Disorders (SAD)- Clinical Trials by Economy Type, 2018
Table 3: Social Anxiety Disorders (SAD)- Clinical Trials by Region, 2018
Table 4: Social Anxiety Disorders (SAD)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Social Anxiety Disorders (SAD)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Social Anxiety Disorders (SAD)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Social Anxiety Disorders (SAD)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Social Anxiety Disorders (SAD)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Social Anxiety Disorders (SAD)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll